ABSTRACT The methyl-accepting chemotaxis proteins (MCPs) of Escherichia coli undergo reversible methylation that has been correlated with adaptation of cells to environmental stimuli. MCPI, the product of the tsr gene, accepts methyl groups at multiple sites that are located on two tryptic peptides, denoted KI Escherichia coli swim in a random walk resulting from alternating clockwise (tumbling behavior) and counterclockwise (straight swimming behavior) flagellar rotation. The bacteria respond to changes in their environment by modulating the probabilities of clockwise and counterclockwise rotations. Cells suppress their tumbling in response to attractants and increase their tumbling in the presence of repellents. Subsequently, the cells undergo a process of adaptation, which entails a return to their prestimulus swimming pattern (1-3).
Escherichia coli swim in a random walk resulting from alternating clockwise (tumbling behavior) and counterclockwise (straight swimming behavior) flagellar rotation. The bacteria respond to changes in their environment by modulating the probabilities of clockwise and counterclockwise rotations. Cells suppress their tumbling in response to attractants and increase their tumbling in the presence of repellents. Subsequently, the cells undergo a process of adaptation, which entails a return to their prestimulus swimming pattern (1) (2) (3) .
These behavioral responses of E. coli to certain stimuli are mediated by a family of transmembrane proteins, the methylaccepting chemotaxis proteins (MCPs) (4) . At least three different MCPs are essential in the sensory transduction process. MCPI, MCPII, and MCPIII, encoded by the tsr, tar, and trg genes, respectively, mediate cellular responses to different subsets of attractants and repellents (5) (6) (7) (8) . A fourth gene, tap, seems to encode an additional MCP whose functional role in chemotaxis has not yet been defined (9) (10) (11) . The behavioral response is initiated by interaction of the effector molecule or an effector-receptor complex in the periplasm with the appropriate MCP (12) (13) (14) (15) (16) .
MCPs undergo reversible methylations in the cell cytoplasm, and changes in the level of methylation correlate with the adaptation of cells to environmental stimuli (6, (17) (18) (19) . Methylation is mediated by a protein methyltransferase encoded by the cheR gene and results in the formation of the ymethyl ester of glutamic acid (20) (21) (22) (23) . A protein methylesterase encoded by the cheB gene balances the methyltransferase activity by removing methyl groups (24, 25) . Each MCP has multiple sites at which methylation and demethylation may occur (26) (27) (28) (29) . For example, MCPI may accept a maximum of six methyl groups, and MCPII accepts at least four methyl groups (30, 31) .
A second covalent modification of the MCPs also occurs at multiple sites and is dependent on the presence of the cheB gene (32, 33) . The chemical nature of the modification, denoted the CheB-dependent modification, had not been identified previously, and its specific role in chemotaxis is unclear. However, several properties suggest that CheB-dependent modification may be the enzymatic conversion of glutamine to glutamic acid residues (32) . Each CheB modification of MCPs results in the addition of one net negative charge to the protein and allows additional methyl groups to be accepted by the MCP (31, 32) .
We have previously shown (30) (34) , these data provide compelling evidence that CheB modification is the enzymatic deamidation of glutamine to glutamic acid. Possible functions for this deamidation in chemotaxis are discussed.
MATERIALS AND METHODS
Strains. E. coli strains and A-E. coli hybrid phage were as described (30, 31) . All strains and phages were the generous gifts of J. S. Parkinson and M. Simon.
Radiolabeling of MCPs, Electrophoresis, Enzyme Digestions, HPLC Analysis, and Isolation of Peptides. These procedures were exactly as described (30, 31) . Neutralized HPLC fractions containing radiolabeled peptides K1 and Ri were pooled and lyophilized directly without removal of sodium phosphate.
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Radiolabeled Sequence Analysis. The sequences shown in Fig. 1 were determined on a spinning cup sequenator with a single cleavage program as described (35, 36 The sequences shown in Fig. 2 were determined on a gasphase sequenator as described (37 (Fig. 3) . Position 10 may also be methylated, suggesting that, as isolated by HPLC from a population of MCPI molecules, peptide T2 may consist of a mixture of monomethylated isomers, each of which is methylated at one of the possible methyl-accepting glutamate residues.
In contrast, sequence analysis of the unmodified [3H]methyllabeled peptide T1 showed the absence of methyl esters at position 3 (Fig. 3) . The data suggest that this peptide contained a methylated residue at position 10, although the peak is broad. This is most likely due to "sequenator lag" which results from incomplete coupling at any or all of the preceding sequenator cycles. In the analyses shown in Fig. 3 , the peptide T1 sample contained twice as much radioactivity as the peptide T2 sample. We therefore believe that the absence of a methyl ester at position 3 in peptide Ti reflects the inability of this residue to accept methyl groups in the absence of CheB-dependent modification. Due to hydrolysis of the methyl esters during sequence analysis, the presence or absence of methyl esters cannot be confirmed at position 17 in the two sequences (Fig. 3) (30) . The predicted sequence contains glutamic acid at position 10 and glutamine at positions 3 and 17 ( Fig. 4; see below) . These positions are observed as methylated sites in peptide K1. The (34) . Amino acid sequences corresponding to the radiolabeled protein sequence determinations in Fig. 1 are shown. Dashes indicate the absence of a radiolabeled residue at that position (see Fig. 2 ). The single-letter code for amino acids is given in Dayhoff (40) Biochemistry: Kehry et al. 3602 Biochemistry: Kehry et aL glutamine positions are compatible with our suggestion that the CheB modification may be the conversion of glutamine to glutamic acid. This does not exclude other sites (residues 4, 9, and 16) as possible methyl-accepting sites. The extensive homology in this region of the tsr and tar genes (41) supports the idea that this sequence contains sites for methyltransferase activity. The nucleotide sequence of tsr predicts that position 3 is a glutamine (Fig. 4) . The identification of positions of methylated residues shows that residue 3 in peptide K1 derived from MCPI synthesized in wild-type cells is a methyl-accepting glutamic acid (Fig. 2) . However, the same residue in the unmodified peptide from MCPI produced in cheB mutants is not methylated. We conclude that the CheB modification of peptide K1 may be the enzymatic conversion of the glutamine at position 3 to methyl-accepting glutamic acid. The CheB-modified and unmodified forms of peptide K1 both accept methyl groups at position 10, which is encoded as glutamic acid in the tsr gene. At this position the methyl-accepting glutamic acid is adjacent to another glutamic acid at position 9 and may account for methylation of the unmodified form. This is consistent with the idea that pairs of glutamic acid residues create a methylaccepting site recognized by the methyltransferase (34) . At position 3, the CheB modification of glutamine to glutamic acid thus results in the formation of a pair of glutamic acid residues (positions 2 and 3), of which position 3 is a methyl-accepting site.
All other properties of the CheB-dependent modification are consistent with its being a deamidation process. Each CheB modification results in the addition of one net negative charge to MCPs (31, 32) . pH-dependent changes in the chromatographic elution position of the modifiable peptide suggest that the CheB-modified group has a pKa similar to that of glutamic acid (42) . CheB modification is irreversible and is stable to basecatalyzed demethylation conditions (31, 32) . The modification allows additional methyl groups to be incorporated into methylaccepting peptide K1 (31) . Because the data are so extensive, we suggest the use of "deamidation" or "CheB-dependent deamidation" rather than the term "modification" for this process.
The sequences shown in Fig. 4 also suggest that the deamidation might occur at a second site in peptide K1 (residue 17) to produce a third methyl-accepting glutamic acid. We previously determined that peptide K1 is subject to only one deamidation yet it may accept two or three additional methyl groups subsequent to this single deamidation (31) . Because the data regarding residue 17 in peptides T1 and T2 are ambiguous (Fig.  3) we can only propose explanations for the apparent discrepancy. First, either residue 3 or residue 17 may be CheB modifiable but, when one site has been modified, the second site is no longer reactive. This would be consistent with the possible methyl-accepting residue at position 17 (Fig. 2) . Second, MCPI could acquire two CheB-dependent deamidations on peptide K1 (residues 3 and 17) only in the presence of CheR, the methyltransferase. We quantitate the number of deamidations on MCPs produced in cells that are cheR (31) (32) (33) ; therefore, this possibility cannot be excluded. Interestingly, the analogous peptide from MCPIII synthesized in cheR cells is subject to two deamidations, suggesting that this limitation or control may no longer hold in minicells (42) (1983) 
